Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MOMETASONE Cause Ejection fraction abnormal? 66 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Ejection fraction abnormal have been filed in association with MOMETASONE (MOMETASONE FUROATE). This represents 3.9% of all adverse event reports for MOMETASONE.

66
Reports of Ejection fraction abnormal with MOMETASONE
3.9%
of all MOMETASONE reports
1
Deaths
60
Hospitalizations

How Dangerous Is Ejection fraction abnormal From MOMETASONE?

Of the 66 reports, 1 (1.5%) resulted in death, 60 (90.9%) required hospitalization.

Is Ejection fraction abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MOMETASONE. However, 66 reports have been filed with the FAERS database.

What Other Side Effects Does MOMETASONE Cause?

Asthma (522) Dyspnoea (497) Wheezing (459) Gastrooesophageal reflux disease (406) Therapeutic product effect incomplete (400) Drug ineffective (318) Sleep disorder due to a general medical condition (318) Cardiac disorder (311) Headache (308) Loss of personal independence in daily activities (301)

What Other Drugs Cause Ejection fraction abnormal?

SACUBITRIL\VALSARTAN (452) METOPROLOL (128) APIXABAN (97) SPIRONOLACTONE (97) MONTELUKAST (93) ALBUTEROL (90) MOMETASONE FUROATE (85) PREDNISONE (85) BUPROPION (72) LEVOTHYROXINE (72)

Which MOMETASONE Alternatives Have Lower Ejection fraction abnormal Risk?

MOMETASONE vs MOMETASONE FUROATE MOMETASONE vs MOMETASONE FUROATE\OLOPATADINE MOMETASONE vs MONOMETHYL MOMETASONE vs MONTELUKAST MOMETASONE vs MONTELUKAST\MONTELUKAST

Related Pages

MOMETASONE Full Profile All Ejection fraction abnormal Reports All Drugs Causing Ejection fraction abnormal MOMETASONE Demographics